scanX
Home
Solara Active Pharma Sciences

Solara Active Pharma Sciences

736.35
-6.60
(-0.89%)
Market Cap (₹ Cr.)
₹3,191
52 Week High
814.00
Book Value
₹259
52 Week Low
263.55
PE Ratio
PB Ratio
2.87
PE for Sector
39.11
PB for Sector
4.60
ROE
-1.48 %
ROCE
-24.73 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-11.73 %
Net Income Growth
-2,448.13 %
Cash Flow Change
-30.32 %
ROE
-3,987.69 %
ROCE
-1,035.57 %
EBITDA Margin (Avg.)
-165.04 %

Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
303
337
360
392
335
356
350
309
353
403
435
454
411
405
105
366
337
342
402
386
354
426
249
301
365
Expenses
256
290
293
322
269
283
266
246
265
300
322
345
314
330
198
349
320
311
349
329
333
391
473
413
321
EBITDA
47
47
66
70
65
73
84
62
88
103
113
109
97
76
-93
16
16
31
52
57
21
35
-224
-112
44
Operating Profit %
15 %
14 %
18 %
17 %
18 %
19 %
23 %
17 %
24 %
24 %
25 %
22 %
23 %
18 %
-98 %
3 %
3 %
8 %
11 %
14 %
5 %
8 %
-90 %
-38 %
12 %
Depreciation
19
19
21
23
23
23
24
24
26
28
27
27
28
28
28
28
28
29
28
26
26
26
26
25
25
Interest
18
20
23
22
19
20
19
20
20
19
20
25
19
17
18
21
23
22
24
22
26
24
25
31
31
Profit Before Tax
10
8
23
25
24
29
41
18
42
56
66
57
51
30
-140
-33
-34
-19
1
8
-30
-15
-275
-168
-12
Tax
2
2
6
6
6
5
5
4
7
10
11
10
9
6
-15
0
0
0
-0
0
0
0
0
0
0
Net Profit
10
8
23
24
24
29
41
18
42
56
66
57
51
30
-140
0
-19
-10
0
6
-20
-15
-275
-256
-12
EPS in ₹
0.40
3.07
9.25
9.14
9.16
11.44
15.95
6.91
15.67
18.97
18.48
15.74
14.07
8.42
-38.85
0.06
-5.33
-2.75
0.12
1.79
-5.52
-4.24
-76.49
-71.23
-3.20
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,817
1,957
2,152
2,610
2,937
2,895
2,347
Fixed Assets
1,063
1,195
1,374
1,359
1,334
1,342
1,261
Current Assets
609
650
675
1,058
1,240
1,191
791
Capital Work in Progress
70
39
40
88
239
238
256
Investments
19
18
18
18
15
16
14
Other Assets
666
705
719
1,145
1,350
1,298
815
Total Liabilities
1,047
994
1,061
1,017
1,410
1,392
1,409
Current Liabilities
732
650
728
785
1,056
1,096
1,238
Non Current Liabilities
315
344
333
232
354
296
172
Total Equity
770
962
1,091
1,593
1,527
1,503
937
Reserve & Surplus
745
937
1,064
1,557
1,491
1,467
901
Share Capital
25
26
27
36
36
36
36
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
32
30
-20
142
-151
-38
-0
Investing Activities
-85
-113
-359
-105
-243
-81
-5
Operating Activities
50
166
242
154
-242
156
111
Financing Activities
67
-23
97
92
334
-113
-107
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
44.11 %
41.07 %
41.07 %
39.51 %
39.71 %
40.40 %
40.40 %
40.40 %
40.97 %
39.31 %
37.19 %
30.49 %
30.49 %
37.27 %
FIIs
13.65 %
16.60 %
17.28 %
18.15 %
19.42 %
17.93 %
18.47 %
19.26 %
0.00 %
18.71 %
17.86 %
16.62 %
15.80 %
14.00 %
DIIs
3.98 %
6.41 %
6.05 %
5.40 %
3.64 %
3.10 %
2.97 %
3.01 %
22.06 %
1.75 %
1.79 %
1.75 %
2.97 %
2.83 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
38.26 %
35.92 %
35.60 %
36.94 %
37.22 %
38.57 %
38.16 %
37.32 %
36.96 %
40.23 %
43.16 %
51.14 %
50.74 %
45.90 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,846.05 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 63.32
Cipla
1,637.70 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 55.49
Zydus Life Science
1,054.45 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 29.67
Dr Reddys Laboratories
6,502.55 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 33.11
Lupin
2,171.90 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 50.58
Mankind Pharma
2,426.05 98,296.04 50.09 10,615.63 19.57 1,942 9.89 55.98
Aurobindo Pharma
1,528.10 90,940.60 25.35 29,559.25 17.55 3,169 61.17 52.33
Alkem Laboratories
6,136.85 74,370.03 34.59 12,978.42 9.84 1,811 91.18 56.16
Glenmark Pharmaceuticals
1,649.80 48,348.71 - 12,653.09 6.58 -1,831 96.52 48.98
Biocon
361.50 45,082.53 28.88 15,621.20 35.25 1,298 478.78 47.25

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.15
ATR(14)
Volatile
37.31
STOCH(9,6)
Neutral
39.48
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-5.87
ADX(14)
Strong Trend
29.46
UO(9)
Bearish
47.53
ROC(12)
Downtrend And Accelerating
-0.20
WillR(14)
Neutral
-54.21
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.